Stigmasterol attenuates hepatic steatosis in rats by strengthening the intestinal barrier and improving bile acid metabolism

肠道菌群 胆汁酸 脂肪变性 鹅去氧胆酸 胆固醇7α羟化酶 血脂异常 脂质代谢 内科学 内分泌学 失调 肝肠循环 脂代谢紊乱 新陈代谢 高脂血症 生物 化学 胆固醇 医学 生物化学 血脂 肥胖 糖尿病
作者
Yaxin Zhang,Yuyan Gu,Jing Jiang,Xiaobing Cui,Saibo Cheng,Linling Liu,Zhiyong Huang,Rongxin Liao,Peng Zhao,Jie-Ying Yu,Jing Wang,Yuhua Jia,Wen Jin,Fenghua Zhou
出处
期刊:npj science of food [Nature Portfolio]
卷期号:6 (1): 38-38 被引量:38
标识
DOI:10.1038/s41538-022-00156-0
摘要

Stigmasterol (ST) has been shown to improve both lipid and bile acid (BA) metabolism. However, the mechanism(s) by which ST prevents dyslipidemia via BA metabolism, and the potential involvement of other regulatory mechanisms, remains unclear. Here, we found that ST treatment effectively alleviates lipid metabolism disorder induced by a high-fat diet (HFD). Moreover, we also show that fecal microbiota transplantation from ST-treated rats displays similar protective effects in rats fed on an HFD. Our data confirm that the gut microbiota plays a key role in attenuating HFD-induced fat deposition and metabolic disorders. In particular, ST reverses HFD-induced gut microbiota dysbiosis in rats by reducing the relative abundance of Erysipelotrichaceae and Allobaculum bacteria in the gut. In addition, ST treatment also modifies the serum and fecal BA metabolome profiles in rats, especially in CYP7A1 mediated BA metabolic pathways. Furthermore, chenodeoxycholic acid combined with ST improves the therapeutic effects in HFD-induced dyslipidemia and hepatic steatosis. In addition, this treatment strategy also alters BA metabolism profiles via the CYP7A1 pathway and gut microbiota. Taken together, ST exerts beneficial effects against HFD-induced hyperlipidemia and obesity with the underlying mechanism being partially related to both the reprogramming of the intestinal microbiota and metabolism of BAs in enterohepatic circulation. This study provides a theoretical basis for further study of the anti-obesity effects of ST and consideration of the gut microbiota as a potential target for the treatment of HFD-induced dyslipidemia.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CipherSage的应助被科研通管家采纳,获得10
1秒前
1秒前
深情安青的应助被科研通管家采纳,获得10
1秒前
一颗苹果的应助被科研通管家采纳,获得10
1秒前
1秒前
汉堡包的应助被科研通管家采纳,获得10
2秒前
Nov_shine完成签到,获得积分10
2秒前
完美世界的应助被科研通管家采纳,获得10
2秒前
ding的应助被科研通管家采纳,获得10
2秒前
大模型的应助被科研通管家采纳,获得20
2秒前
一颗苹果的应助被科研通管家采纳,获得10
2秒前
2秒前
molihuakai的应助被科研通管家采纳,获得10
2秒前
3秒前
3秒前
shuyiWang发布了新的文献求助10
3秒前
3秒前
4秒前
dong完成签到,获得积分10
5秒前
采一发布了新的文献求助10
5秒前
Hello的应助被xxx采纳,获得10
6秒前
可乐加糖发布了新的文献求助30
6秒前
不能熬夜发布了新的文献求助10
7秒前
科研通AI6.3的应助被Changfh采纳,获得10
8秒前
Owen的应助被友好的诗筠采纳,获得10
9秒前
二二春发布了新的文献求助10
9秒前
Firsterchao的应助被Stella采纳,获得10
9秒前
诚心的凡雁的应助被369ninja采纳,获得10
11秒前
13秒前
13秒前
NexusExplorer的应助被风趣冬瓜采纳,获得10
14秒前
酷波er的应助被森屿寻风采纳,获得10
15秒前
文2026发布了新的文献求助10
16秒前
19秒前
动人的亦云完成签到,获得积分10
19秒前
zombie发布了新的文献求助10
20秒前
科研通AI6.3的应助被晚风采纳,获得30
21秒前
wanci的应助被00hello00采纳,获得10
22秒前
Jasper的应助被长情的雨采纳,获得10
23秒前
小蘑菇的应助被sfliufighting采纳,获得10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184508
求助须知:如何正确求助?哪些是违规求助? 9573478
关于积分的说明 21831914
捐赠科研通 7781737
什么是DOI,文献DOI怎么找? 3434372
关于科研通互助平台的介绍 2558482
邀请新用户注册赠送积分活动 2480962